Trimedyne Shares Resume Nasdaq Trading

Trimedyne Inc.’s stock is trading again after an interruption in market activity that the company blamed on a “clerical error.”

Nasdaq market officials halted trading of the medical laser designer’s shares Friday. Trimedyne said that was because Nasdaq was awaiting proof that the company has a valid Nevada corporate charter.

Trimedyne was late in getting that information to Nasdaq because the company’s corporate charter had temporarily lapsed when a form was not filled with the state on time, Trimedyne said.

Trimedyne’s stock closed unchanged Wednesday at 94 cents.